Rare cancer comes of (molecular) age

Mae’r cynnwys hwn wedi dod o wefan allanol ac mae ar gael yn Saesneg yn unig

This session, from the National Cancer Research Institute is chaired by Professor Richard Wilson from the University of Glasgow, and will demonstrate the great progress that has been made recently in rare cancer research. For example, biliary tract cancer can now be treated using personalized medicine approaches, and small bowel adenocarcinoma is now understood to have different genetic drivers than gastric and colorectal cancer - updates and therapeutic approaches will be given on these. A general overview of genomic profiling and its use in early and late phase trials in rare cancers will also be discussed.

You will be joined by: 

• Dr Mairéad Mcnamara - University of Manchester/The Christie NHS Foundation Trust, UK
• Professor Michael Overman - The University of Texas, USA
• Professor Thomas Aparicio - Saint Louis Hospital, France

There will be an opportunity for attendees to submit questions live.